Quarterly report pursuant to Section 13 or 15(d)

Statements of Stockholders??? (Deficit) Equity

v3.21.2
Statements of Stockholders’ (Deficit) Equity - USD ($)
$ in Thousands
Common Stock
Preferred stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 8 $ 2,766 $ (3,658) $ (884)
Balance (in Shares) at Dec. 31, 2019 8,456,179      
Net loss (unaudited) (344) (344)
Issuance of common stock for cash (unaudited) 50 50
Issuance of common stock for cash (unaudited) (in Shares) 11,862        
Issuance of common stock for anti-dilution clause (unaudited) 2 2
Issuance of common stock for anti-dilution clause (unaudited) (in Shares) 475        
Stock-based compensation expense (unaudited) 31 31
Balance at Mar. 31, 2020 $ 8 2,849 (4,002) (1,145)
Balance (in Shares) at Mar. 31, 2020 8,468,516        
Net loss (unaudited) (338) (338)
Issuance of common stock for cash (unaudited) $ 1 91 92
Issuance of common stock for cash (unaudited) (in Shares) 21,401        
Issuance of common stock for anti-dilution clause (unaudited) 28 28
Issuance of common stock for anti-dilution clause (unaudited) (in Shares) 6,624        
Stock-based compensation expense (unaudited) 60 60
Balance at Jun. 30, 2020 $ 9 3,028 (4,340) (1,303)
Balance (in Shares) at Jun. 30, 2020 8,496,541        
Net loss (unaudited) (702) (702)
Issuance of common stock for anti-dilution clause (unaudited) 74 74
Issuance of common stock for anti-dilution clause (unaudited) (in Shares) 17,529        
Stock-based compensation expense (unaudited) 71 71
Balance at Sep. 30, 2020 $ 9   3,173 (5,042) (1,860)
Balance (in Shares) at Sep. 30, 2020 8,514,070        
Balance at Dec. 31, 2020 $ 9 3,242 (5,922) (2,671)
Balance (in Shares) at Dec. 31, 2020 8,514,070        
Net loss (unaudited) (964) (964)
Issuance of common stock for exercise of options (unaudited) 31 31
Issuance of common stock for exercise of options (unaudited) (in Shares) 233,819        
Stock-based compensation expense (unaudited) 202 202
Balance at Mar. 31, 2021 $ 9 3,475 (6,886) (3,402)
Balance (in Shares) at Mar. 31, 2021 8,747,889        
Net loss (unaudited) (1,100) (1,100)
Issuance of common stock for exercise of options (unaudited) 6 6
Issuance of common stock for exercise of options (unaudited) (in Shares) 23,401        
Stock-based compensation expense (unaudited) 294 294
Balance at Jun. 30, 2021 $ 9 3,775 (7,986) (4,202)
Balance (in Shares) at Jun. 30, 2021 8,771,290        
Net loss (unaudited) (5,201) (5,201)
Conversion of convertible notes into common stock (unaudited) $ 1 3,684 3,685
Conversion of convertible notes into common stock (unaudited) (in Shares) 736,773        
Issuance of common stock for exercise of options (unaudited) 14 14
Issuance of common stock for exercise of options (unaudited) (in Shares) 26,115        
Issuance of common stock for cash (unaudited) $ 5 22,266 22,271
Issuance of common stock for cash (unaudited) (in Shares) 5,000,000        
Issuance of common stock for anti-dilution clause (unaudited) 2,191 2,191
Issuance of common stock for anti-dilution clause (unaudited) (in Shares) 438,374        
Stock-based compensation expense (unaudited) 239 239
Balance at Sep. 30, 2021 $ 15 $ 32,169 $ (13,187) $ 18,997
Balance (in Shares) at Sep. 30, 2021 14,972,552